About this FactMed analysis covering adverse side effect reports of METARAMINOL patients who developed AKINESIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 2 individuals taking METARAMINOL reported AKINESIA to the FDA. A total of 40 METARAMINOL drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between METARAMINOL and AKINESIA. In doing so, we compare METARAMINOL with other drugs that cause AKINESIA, to help you evaluate whether or not METARAMINOL causes AKINESIA. Likewise, this page shows the most highly-reported side effects of METARAMINOL, so you can see if AKINESIA ranks among METARAMINOL's most well-known side effects.
Summary Statistics
Reports of METARAMINOL causing AKINESIA: 2
Reports of any side effect of METARAMINOL : 40
Percentage of METARAMINOL patients where AKINESIA is a reported side effect: 5.0000%

FDA reports of any drug causing AKINESIA : 753
Average percentage for all medicated patients where AKINESIA is reported as a complication: 0.0047%

Physician opinion on METARAMINOL as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing METARAMINOL:
DRUG USE FOR UNKNOWN INDICATION ( 8 patients )
HYPOTENSION ( 6 patients )
CATHETER PLACEMENT ( 3 patients )
PROCEDURAL HYPOTENSION ( 3 patients )
BLOOD PRESSURE MANAGEMENT ( 1 patients )
PERIOPERATIVE ANALGESIA ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with AKINESIA:

MODOPAR (292 patients)
EFFEXOR (145 patients)
XANAX (129 patients)
VIOXX (116 patients)
STALEVO 100 (111 patients)
ASPIRIN (73 patients)
PERGOLIDE MESYLATE (56 patients)
SINEMET (55 patients)
RISPERDAL (54 patients)
ATHYMIL (52 patients)
COMTAN (45 patients)
MADOPAR (41 patients)
LORAZEPAM (40 patients)
MADOPAR DISPERSIBLE (39 patients)
IMOVANE (38 patients)
ZYPREXA (37 patients)
ATARAX (37 patients)
VALPROATE SODIUM (36 patients)
CLOZAPINE (31 patients)
DEPAKOTE (30 patients)
CITALOPRAM HYDROBROMIDE (29 patients)
CLOBAZAM (29 patients)
FUROSEMIDE (28 patients)
REQUIP (28 patients)
PARLODEL (27 patients)
EXELON (27 patients)
PAXIL (26 patients)
DIGOXIN (25 patients)
LASIX (25 patients)
ERYTHROMYCIN (25 patients)
SEROQUEL (25 patients)
LAMOTRIGINE (25 patients)
RISPERIDONE (24 patients)
GENTAMICIN (24 patients)
PHENYTOIN (23 patients)
AMANTADINE HCL (23 patients)
ACETAMINOPHEN (21 patients)
HALDOL (21 patients)
DIAZEPAM (20 patients)
VALTREX (20 patients)
OMEPRAZOLE (19 patients)
PAROXETINE HCL (19 patients)
ACETAMINOPHEN AND TRAMADOL HCL (18 patients)
CEFOTAXIME (18 patients)
SPIRONOLACTONE (18 patients)
LEVOTHYROXINE SODIUM (18 patients)
TEGRETOL (17 patients)
PREDNISOLONE (17 patients)
DEPAKENE (17 patients)
HALOPERIDOL (17 patients)
SIMVASTATIN (16 patients)
NITROGLYCERIN (16 patients)
ZOLOFT (15 patients)
PIPERACILLIN (15 patients)
LIPITOR (15 patients)
LEXOMIL (14 patients)
CLOPIDOGREL (14 patients)
OLANZAPINE (14 patients)
CABERGOLINE (14 patients)
TEMESTA (14 patients)
CLONAZEPAM (14 patients)
IBUPROFEN (14 patients)
NEURONTIN (13 patients)
LEVODOPA (13 patients)
WARFARIN SODIUM (13 patients)
SERENACE (13 patients)
OXYCONTIN (13 patients)
MEMANTINE HCL (13 patients)
ATENOLOL (13 patients)
DIOVAN (12 patients)
HIZENTRA (12 patients)
PRAMIPEXOLE DIHYDROCHLORIDE (12 patients)
ALBUTEROL (12 patients)
CELEBREX (12 patients)
HEPARIN (12 patients)
SEROQUEL XR (12 patients)
ENOXAPARIN SODIUM (12 patients)
ATORVASTATIN CALCIUM (12 patients)
ABILIFY (11 patients)
PLAVIX (11 patients)
FLUOXETINE (11 patients)
LOXAPINE HCL (11 patients)
COREG (11 patients)
TAXOTERE (11 patients)
GLEEVEC (11 patients)
VENLAFAXINE (11 patients)
PREVACID (11 patients)
CAPTOPRIL (11 patients)
CIPRO (11 patients)
CYCLOSPORINE (11 patients)
LANTUS (10 patients)
SYNTHROID (10 patients)
ACTONEL (10 patients)
MIRAPEX (10 patients)
KETOCONAZOLE (10 patients)
ANTIBIOTICS (10 patients)
ARICEPT (10 patients)
HEPARIN SODIUM INJECTION (10 patients)
AVONEX (10 patients)
RAMIPRIL (9 patients)
INSULIN (9 patients)
NECYRANE (9 patients)
MORPHINE (9 patients)
FERROUS SULFATE TAB (9 patients)
PRAZEPAM (9 patients)
DONEPEZIL HCL (9 patients)
CARBOCISTEINE (9 patients)
EXTAVIA (9 patients)
BROMOCRIPTINE MESYLATE (9 patients)
AMBIEN (9 patients)
AMOXICILLIN (9 patients)
RISPERDAL CONSTA (9 patients)
LAMICTAL (9 patients)
SINGULAIR (9 patients)
ECONAZOLE NITRATE (9 patients)
ARTANE (9 patients)
FOLIC ACID (9 patients)
PRAMIPEXOLE DIHYCHLLORIDE (9 patients)
LISINOPRIL (9 patients)
CEFUROXIME (9 patients)
LYSOPAINE (9 patients)
PRILOSEC (9 patients)
HYDROCHLOROTHIAZIDE (9 patients)
SANDIMMUNE (9 patients)
CYMBALTA (8 patients)
ELUDRIL (8 patients)
MIRTAZAPINE (8 patients)
SOLANAX (8 patients)
EPINEPHRINE (8 patients)
TYLENOL (CAPLET) (8 patients)
CIATYL Z (8 patients)
TRAMAL (8 patients)
AMIODARONE HCL (8 patients)
COUMADIN (8 patients)
NEUROCIL (8 patients)
OXAZEPAM (8 patients)
LEVEMIR (8 patients)
AVANDIA (8 patients)
NEXIUM (8 patients)
PROTONIX (8 patients)
ZOCOR (8 patients)
WELLBUTRIN (8 patients)
BIPERIDEN HYDROCHLORIDE TAB (8 patients)
METFORMIN HCL (7 patients)
NORVASC (7 patients)
METOPROLOL (7 patients)
TRIVASTAL (7 patients)
ZANAFLEX (7 patients)
HUMIRA (7 patients)
ALDACTONE (7 patients)
SOLU-CORTEF (7 patients)
ALLOPURINOL (7 patients)
TRIHEXYPHENIDYL HCL (7 patients)
PREVISCAN (7 patients)
DOPAMINE HCL (7 patients)
SERTRALINE HCL (7 patients)
THIOPENTAL SODIUM (7 patients)
ENALAPRIL MALEATE (7 patients)
BISOPROLOL FUMARATE (7 patients)
TRAZODONE HCL (7 patients)
LITHIUM CARBONATE (7 patients)
TYLENOL (7 patients)
TRANXENE (7 patients)
POTASSIUM CHLORIDE (7 patients)
CEFOTAXIME SODIUM (7 patients)
PREDONINE (7 patients)
ISOSORBIDE DINITRATE (7 patients)
CYTARABINE (7 patients)
VITAMIN D (7 patients)
CARBIDOPA AND LEVODOPA (6 patients)
LOVENOX (6 patients)
ACETYLSALICYLIC ACID SRT (6 patients)
ESCITALOPRAM (6 patients)
DEXAMETHASONE TAB (6 patients)
SERTRALINE HYDROCHLORIDE (6 patients)
EVEROLIMUS (6 patients)
TASMAR (6 patients)
ALPRAZOLAM (6 patients)
MANTADIX (6 patients)
PRAZINE (6 patients)
HERCEPTIN (6 patients)
DEROXAT (6 patients)
AMLODIPINE (6 patients)
METHYLPREDNISOLONE (6 patients)
PURSENNID (6 patients)
REMICADE (6 patients)
SILECE (6 patients)
ZOVIRAX (6 patients)
MYCOPHENOLATE MOFETIL (6 patients)
ARAVA (6 patients)
LEPTICUR (6 patients)
CARBAMAZEPINE (6 patients)
TOBRAMYCIN (6 patients)
SYMMETREL (6 patients)
ATIVAN (6 patients)
ATORVASTATIN (6 patients)
CIPRALEX (ESCITALOPRAM) (6 patients)
LYRICA (6 patients)
CLARITHROMYCIN (6 patients)
CITALOPRAM (6 patients)
VANCOMYCIN (6 patients)
HEPTAMINOL (6 patients)
AZILECT (6 patients)
HUMALOG (6 patients)
PREDNISONE TAB (6 patients)
PROPRANOLOL (6 patients)
PROCTOLOG (6 patients)
INTETRIX (6 patients)
RANITIDINE (6 patients)
MS CONTIN (5 patients)
Most common side effects for patients taking METARAMINOL:
METABOLIC ACIDOSIS (8 patients)
HYPOTENSION (8 patients)
CARDIOVASCULAR DISORDER (5 patients)
HEPATIC FUNCTION ABNORMAL (5 patients)
DRUG EXPOSURE DURING PREGNANCY (5 patients)
TACHYCARDIA (4 patients)
DRUG INEFFECTIVE (4 patients)
WOUND SECRETION (3 patients)
ABDOMINAL PAIN UPPER (3 patients)
VENTRICULAR FIBRILLATION (3 patients)
RENAL IMPAIRMENT (3 patients)
RENAL DISORDER (3 patients)
PSYCHOTIC DISORDER (3 patients)
PANCREATITIS (3 patients)
NAUSEA (3 patients)
LIVER DISORDER (3 patients)
HYPOGLYCAEMIA (3 patients)
HYPERTHERMIA MALIGNANT (3 patients)
DRUG INTERACTION (3 patients)
DEHYDRATION (2 patients)
OPERATIVE HAEMORRHAGE (2 patients)
VOMITING (2 patients)
VENTRICULAR DYSFUNCTION (2 patients)
TRICUSPID VALVE INCOMPETENCE (2 patients)
COUGH (2 patients)
DYSKINESIA (2 patients)
EJECTION FRACTION DECREASED (2 patients)
EMOTIONAL DISTRESS (2 patients)
THROMBOSIS (2 patients)
AKINESIA (2 patients)
SINUS RHYTHM (2 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (2 patients)
ANXIETY (2 patients)
PCO2 INCREASED (2 patients)
OEDEMA PERIPHERAL (2 patients)
CHEST PAIN (2 patients)
HEPATOCELLULAR DAMAGE (2 patients)
MYOCARDIAL ISCHAEMIA (2 patients)
MITRAL VALVE INCOMPETENCE (2 patients)
CARDIOMEGALY (2 patients)
CAESAREAN SECTION (2 patients)
CARDIAC DISORDER (2 patients)
INTESTINAL INFARCTION (2 patients)
ABDOMINAL PAIN (2 patients)
LIPASE INCREASED (1 patients)
HYPOXIA (1 patients)
LUNG INFILTRATION (1 patients)
CARDIAC FAILURE (1 patients)
CARDIOMYOPATHY (1 patients)
MOOD ALTERED (1 patients)
HEPATOTOXICITY (1 patients)
BRADYCARDIA (1 patients)
HEART RATE INCREASED (1 patients)
DIZZINESS (1 patients)
ORAL INTAKE REDUCED (1 patients)
BLOOD PRESSURE DECREASED (1 patients)
HAEMOGLOBIN INCREASED (1 patients)
PERIPARTUM CARDIOMYOPATHY (1 patients)
PLATELET COUNT DECREASED (1 patients)
PNEUMONITIS (1 patients)
POSTPARTUM HAEMORRHAGE (1 patients)
PROCEDURAL COMPLICATION (1 patients)
BLADDER DISTENSION (1 patients)
RED BLOOD CELL COUNT DECREASED (1 patients)
HAEMATOCRIT DECREASED (1 patients)
ANAPHYLACTIC REACTION (1 patients)
REPERFUSION INJURY (1 patients)
RESPIRATORY FAILURE (1 patients)
SEROTONIN SYNDROME (1 patients)
SHOCK (1 patients)
FIBRINOLYSIS (1 patients)
SKIN TEST POSITIVE (1 patients)
SLEEP DISORDER (1 patients)
EYE SWELLING (1 patients)
THERAPY NON-RESPONDER (1 patients)
ERYTHEMA (1 patients)
CREATINE URINE INCREASED (1 patients)
TUMOUR MARKER INCREASED (1 patients)
UNWANTED AWARENESS DURING ANAESTHESIA (1 patients)
URINE OUTPUT DECREASED (1 patients)
UTERINE ATONY (1 patients)
UTERINE HAEMORRHAGE (1 patients)
DRUG HYPERSENSITIVITY (1 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (1 patients)
DEAFNESS NEUROSENSORY (1 patients)
WHEEZING (1 patients)
LIP SWELLING (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for METARAMINOL


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about AKINESIA and METARAMINOL, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking METARAMINOL, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in METARAMINOL. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for METARAMINOL experts. If you are a healthcare provider experienced in prescribing METARAMINOL, please register here.

Your online appointment book for Vivian Rentals & Services



© 2014 FactMed, Inc
Privacy Policy
Terms of Use